Pregled bibliografske jedinice broj: 649803
R&D Efficiency for Pharmaceutical Companies in the EU
R&D Efficiency for Pharmaceutical Companies in the EU // International journal of economics and statistics, 1 (2013), 1; 209-215 (podatak o recenziji nije dostupan, članak, znanstveni)
CROSBI ID: 649803 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
R&D Efficiency for Pharmaceutical Companies in the EU
Autori
Bezić Heri ; Galović Tomislav ; Mišević Petar
Izvornik
International journal of economics and statistics (2309-0685) 1
(2013), 1;
209-215
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
DEA efficiency ; R&D performance ; EU pharmaceutical companies
Sažetak
This study constructs research and development (R&D) as a factor of productivity of European pharmaceutical industry. We introduce an empirical model derived from the Data Envelopment Analysis model to calculate R&D and efficiencies for selected European pharmaceutical companies. This research brings a mathematical view with Data Envelopment Analysis which is a mathematical modeling method of calculating relative efficiencies of Decision Making Units (DMUs), based on predetermined inputs and outputs. Performance evaluation of R&D activity is important for continuous improvement of performance of pharmaceutical companies. The model was used to obtain the overall level of exports with input factors of R&D activity. The subject of analysis are efficiency values and rank. After identifying relative efficiencies of the observed countries, the results are discussed.
Izvorni jezik
Engleski
Znanstvena područja
Ekonomija
POVEZANOST RADA
Projekti:
081-0811403-1414 - Inovativnost, transfer tehnologije i konkurentnost hrvatskog izvoza (Bezić, Heri, MZOS ) ( CroRIS)
Ustanove:
Ekonomski fakultet, Rijeka,
Sveučilište Libertas